Tert-butyl N-[[3-amino-6-(2,4-dichlorophenyl)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;tert-butyl N-[[6-(2,4-dichlorophenyl)-3-(oxane-4-carbonylamino)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridin-3-amine;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridine;oxane-4-carboxylic acid
C78H73Cl8N15O9 — CID 157325695
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[[3-amino-6-(2,4-dichlorophenyl)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;tert-butyl N-[[6-(2,4-dichlorophenyl)-3-(oxane-4-carbonylamino)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridin-3-amine;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridine;oxane-4-carboxylic acid
Tert-butyl N-[[3-amino-6-(2,4-dichlorophenyl)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;tert-butyl N-[[6-(2,4-dichlorophenyl)-3-(oxane-4-carbonylamino)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridin-3-amine;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridine;oxane-4-carboxylic acid (PubChem CID 157325695) has the molecular formula C78H73Cl8N15O9 and a molecular weight of 1648.16 g/mol. Its IUPAC name is tert-butyl N-[[3-amino-6-(2,4-dichlorophenyl)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;tert-butyl N-[[6-(2,4-dichlorophenyl)-3-(oxane-4-carbonylamino)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridin-3-amine;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridine;oxane-4-carboxylic acid.
Molecular Properties
| Compound Name | Tert-butyl N-[[3-amino-6-(2,4-dichlorophenyl)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;tert-butyl N-[[6-(2,4-dichlorophenyl)-3-(oxane-4-carbonylamino)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridin-3-amine;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridine;oxane-4-carboxylic acid |
|---|---|
| PubChem CID | 157325695 |
| Molecular Formula | C78H73Cl8N15O9 |
| Molecular Weight | 1648.16 g/mol |
| Exact Mass | 1643.32 |
| IUPAC Name | tert-butyl N-[[3-amino-6-(2,4-dichlorophenyl)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;tert-butyl N-[[6-(2,4-dichlorophenyl)-3-(oxane-4-carbonylamino)imidazo[1,2-a]pyridin-7-yl]methyl]carbamate;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridin-3-amine;6-(2,4-dichlorophenyl)-7-isocyanoimidazo[1,2-a]pyridine;oxane-4-carboxylic acid |
| SMILES | CC(C)(C)OC(=O)NCc1cc2ncc(N)n2cc1-c1ccc(Cl)cc1Cl.CC(C)(C)OC(=O)NCc1cc2ncc(NC(=O)C3CCOCC3)n2cc1-c1ccc(Cl)cc1Cl.O=C(O)C1CCOCC1.[C-]#[N+]c1cc2ncc(N)n2cc1-c1ccc(Cl)cc1Cl.[C-]#[N+]c1cc2nccn2cc1-c1ccc(Cl)cc1Cl |
| InChI | InChI=1S/C25H28Cl2N4O4.C19H20Cl2N4O2.C14H8Cl2N4.C14H7Cl2N3.C6H10O3/c1-25(2,3)35-24(33)29-12-16-10-21-28-13-22(30-23(32)15-6-8-34-9-7-15)31(21)14-19(16)18-5-4-17(26)11-20(18)27;1-19(2,3)27-18(26)24-8-11-6-17-23-9-16(22)25(17)10-14(11)13-5-4-12(20)7-15(13)21;1-18-12-5-14-19-6-13(17)20(14)7-10(12)9-3-2-8(15)4-11(9)16;1-17-13-7-14-18-4-5-19(14)8-11(13)10-3-2-9(15)6-12(10)16;7-6(8)5-1-3-9-4-2-5/h4-5,10-11,13-15H,6-9,12H2,1-3H3,(H,29,33)(H,30,32);4-7,9-10H,8,22H2,1-3H3,(H,24,26);2-7H,17H2;2-8H;5H,1-4H2,(H,7,8) |
| InChIKey | BERPUKPGLBSIPU-UHFFFAOYSA-N |
| XLogP | 20.41 |
| TPSA | 291.48 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 110 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1648.16 |
| LogP ≤ 5 | 20.41 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157325695 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.